SRPT vs UBER · rev $1.90B vs P/E 18, rev $52.02B
Sarepta Therapeutics Inc (SRPT) versus Uber Technologies Inc (UBER) — a side-by-side from cached financials, not a winner call.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Uber Technologies Inc (UBER) is a software - application company listed on NYSE. It is led by Dara Khosrowshahi.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
Latest reported UBER revenue for 2025-12-31 was $52.02B. Net income was $10.05B. Revenue was up 18.3% from 2024-12-31 to 2025-12-31. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
SRPT currently screens at market cap $2.34B. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
Not investment advice. Open the SRPT and UBER stock pages for the full models.
Not investment advice.